MCC-Office of Translational Science Retreat  

“Sparkathon” 

Join us for our first annual Office of Translational Science Retreat.  Our goal of our retreat (“Sparkathon”) is to “spark” collaborative translational efforts and foster networking among researchers across diverse disciplines and research programs. Dr. Himisha Beltran (Dana-Farber Cancer Institute) is the keynote speaker, a medical oncologist and physician scientist focused on understanding mechanisms of treatment resistance in prostate cancer and lineage plasticity during cancer evolution. The keynote and associated panel discussion will offer insights into vital translational processes, and there will be time for Q & A. The retreat will also feature a community-scientist program, rapid-fire translational science talks, structured networking sessions, and a fun and competitive opportunity to pitch a translational concept for seed funding.

Wednesday, February 7, 2024

10:00 a.m. to 5:30 p.m.

Goldberg Auditorium

Moores Cancer Center

RSVP is required for this event for catering purposes. After clicking on the RSVP button here, please use the "Respond" button on the following page to RSVP. Thank you!

Meet Our Keynote Speaker

Himisha Beltran, MD

Dissecting Mechanisms of Resistance in Prostate Cancer: Successes and Failures in Translational Research

Dr. Beltran is a medical oncologist and physician scientist focused on understanding mechanisms of treatment resistance in prostate cancer and lineage plasticity during cancer evolution. She is an Associate Professor of Medicine in the Department of Medical Oncology in the Lank Division of Genitourinary Oncology and the Division of Molecular and Cellular Oncology at DFCI and Harvard Medical School. Her lab has specifically focused on the mechanisms underlying the development of neuroendocrine prostate cancer, an aggressive subtype of advanced prostate cancer. Dr. Beltran is also the  Correlative Science Committee Chair for the Alliance for Clinical Trials in Oncology GU Committee and plays an active role in several national and international committees and programs including ASCO, ESMO, as well as team science projects such as the SU2C-PCF Dream Team and PCF SELECT. She serves as Director of Translational Research with  Medical Oncology at DFCI and co-PI of the DF/HCC Prostate Cancer SPORE in Prostate Cancer. Dr. Beltran works closely with a multidisciplinary team to translate new scientific discoveries into the clinic in the form of biomarker-driven therapeutics to improve patient care. 

Found in Translation (FiT) | Concept Seed Funding Opportunity

Selected presenters:

Yu-Wei Chen, Christina Jamieson

Dissecting the impact of carbonic anhydrase 9 (CA9) expression in renal cell carcinoma 

Omar Din, Kay Yeung, Rob Knight

Illuminating host-microbiome relationships in triple-negative breast cancer using spatial transcriptomics and long-read metagenomics 

Theresa Guo, Soo Park

Defining the immune microenvironment of cutaneous squamous cell carcinoma in solid organ transplant patients 

Jyoti Mayadev, Sonia Sharma, Karcher Morris

Development of a novel biomechanical device for vaginal stenosis after radiation therapy for cervical cancer 

Contact Us

Visit Our Website

Department of Research Administration

3855 Health Sciences Drive, La Jolla, CA 92037

moorescancercenter.ucsd.edu